Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
St. Louis University Hospital Cancer Center
mi
from
Saint Louis, MO
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
St. Louis University Hospital Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
Lincoln Medical & Mental Health Center
mi
from
Bronx, NY
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
Lincoln Medical & Mental Health Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
HemOnCare, P.C.
mi
from
Brooklyn, NY
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
HemOnCare, P.C.
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
Charleston Hematology Oncology, PA
mi
from
Charleston, SC
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
Charleston Hematology Oncology, PA
mi
from
Charleston, SC
Click here to add this to my saved trials
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
Cancer Center at the University of Virginia
mi
from
Charlottesville, VA
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
Cancer Center at the University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
mi
from
Seattle, WA
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
Rockwood Clinic, PS
mi
from
Spokane, WA
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
Rockwood Clinic, PS
mi
from
Spokane, WA
Click here to add this to my saved trials
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/16/2016
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/16/2016
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
Click here to add this to my saved trials
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
A Single Arm Phase II Study of the Efficacy, Safety, and Biomarkers of Activity of E7820 Plus Cetuximab in Advanced Solid Tumors Preceded by a Run-In Study to Determine Safety of the Combination
Status: Enrolling
Updated:  3/28/2016
Clinical Research Facility
mi
from
Los Angeles, CA
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
A Single Arm Phase II Study of the Efficacy, Safety, and Biomarkers of Activity of E7820 Plus Cetuximab in Advanced Solid Tumors Preceded by a Run-In Study to Determine Safety of the Combination
Status: Enrolling
Updated: 3/28/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
A Single Arm Phase II Study of the Efficacy, Safety, and Biomarkers of Activity of E7820 Plus Cetuximab in Advanced Solid Tumors Preceded by a Run-In Study to Determine Safety of the Combination
Status: Enrolling
Updated:  3/28/2016
Clinical Research Facility
mi
from
Miami, FL
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
A Single Arm Phase II Study of the Efficacy, Safety, and Biomarkers of Activity of E7820 Plus Cetuximab in Advanced Solid Tumors Preceded by a Run-In Study to Determine Safety of the Combination
Status: Enrolling
Updated: 3/28/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
A Single Arm Phase II Study of the Efficacy, Safety, and Biomarkers of Activity of E7820 Plus Cetuximab in Advanced Solid Tumors Preceded by a Run-In Study to Determine Safety of the Combination
Status: Enrolling
Updated:  3/28/2016
mi
from
Edmonton,
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
A Single Arm Phase II Study of the Efficacy, Safety, and Biomarkers of Activity of E7820 Plus Cetuximab in Advanced Solid Tumors Preceded by a Run-In Study to Determine Safety of the Combination
Status: Enrolling
Updated: 3/28/2016
mi
from
Edmonton,
Click here to add this to my saved trials
Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer
Phase I Evaluation of Semi-continuous Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/31/2016
University of Cancer Institute
mi
from
Pittsburgh, PA
Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer
Phase I Evaluation of Semi-continuous Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/31/2016
University of Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
NEA Baptist Clinic
mi
from
Jonesboro, AR
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
NEA Baptist Clinic
mi
from
Jonesboro, AR
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Florida Cancer Specialists - South
mi
from
Fort Myers, FL
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Florida Cancer Specialists - South
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Woodlands Medical Specialists
mi
from
Pensacola, FL
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Woodlands Medical Specialists
mi
from
Pensacola, FL
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Florida Cancer Specialists-North
mi
from
St. Petersburg, FL
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Florida Cancer Specialists-North
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Oncology Hematology of SW Indiana
mi
from
Newburgh, IN
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Oncology Hematology of SW Indiana
mi
from
Newburgh, IN
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Hope Cancer Center
mi
from
Terre Haute, IN
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Hope Cancer Center
mi
from
Terre Haute, IN
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Grand Rapids Oncology Program
mi
from
Grand Rapids, MI
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Grand Rapids Oncology Program
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Nebraska Methodist Hospital
mi
from
Omaha, NE
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Nebraska Methodist Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Atlantic Health System
mi
from
Summit, NJ
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Atlantic Health System
mi
from
Summit, NJ
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated:  4/1/2016
Texas Health Physician Group
mi
from
Dallas, TX
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Status: Enrolling
Updated: 4/1/2016
Texas Health Physician Group
mi
from
Dallas, TX
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Florida Cancer Specialists
mi
from
Fort Myers, FL
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Florida Cancer Specialists
mi
from
Fort Myers, FL
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Woodlands Medical Specialists
mi
from
Pensacola, FL
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Woodlands Medical Specialists
mi
from
Pensacola, FL
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Florida Cancer Specialists, Site #179
mi
from
St. Petersburg, FL
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Florida Cancer Specialists, Site #179
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Space Coast Cancer Center
mi
from
Titusville, FL
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Space Coast Cancer Center
mi
from
Titusville, FL
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Baptist Hospital East
mi
from
Louisville, KY
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Baptist Hospital East
mi
from
Louisville, KY
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Oncology Hematology Care
mi
from
Cincinnati, OH
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Oncology Hematology Care
mi
from
Cincinnati, OH
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Oklahoma University
mi
from
Oklahoma City, OK
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Oklahoma University
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Tennessee Oncology-Chattanooga
mi
from
Chattanooga, TN
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Tennessee Oncology-Chattanooga
mi
from
Chattanooga, TN
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated:  4/1/2016
Virginia Cancer Institute
mi
from
Richmond, VA
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Status: Enrolling
Updated: 4/1/2016
Virginia Cancer Institute
mi
from
Richmond, VA
Click here to add this to my saved trials
Non-Invasive Prediction of Colorectal Neoplasia
Non-Invasive Prediction of Colorectal Neoplasia
Status: Enrolling
Updated:  4/1/2016
Philadelphia VAMC
mi
from
Philadelphia, PA
Non-Invasive Prediction of Colorectal Neoplasia
Non-Invasive Prediction of Colorectal Neoplasia
Status: Enrolling
Updated: 4/1/2016
Philadelphia VAMC
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
Status: Enrolling
Updated:  4/6/2016
Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
Status: Enrolling
Updated: 4/6/2016
Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated:  4/6/2016
California Cancer Registry
mi
from
Sacramento, CA
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated: 4/6/2016
California Cancer Registry
mi
from
Sacramento, CA
Click here to add this to my saved trials
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated:  4/6/2016
Colorado Central Cancer Registry
mi
from
Denver, CO
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated: 4/6/2016
Colorado Central Cancer Registry
mi
from
Denver, CO
Click here to add this to my saved trials
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated:  4/6/2016
Cancer Data Registry of Idaho
mi
from
Boise, ID
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated: 4/6/2016
Cancer Data Registry of Idaho
mi
from
Boise, ID
Click here to add this to my saved trials
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated:  4/6/2016
University of New Mexico
mi
from
Albuquerque, NM
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated: 4/6/2016
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated:  4/6/2016
Utah Cancer Registry
mi
from
Salt Lake City, UT
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated: 4/6/2016
Utah Cancer Registry
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated:  4/6/2016
University of Colorado Cancer Center
mi
from
Aurora, CO
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated: 4/6/2016
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated:  4/6/2016
Intermountain Health Care
mi
from
Salt Lake City, UT
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated: 4/6/2016
Intermountain Health Care
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated:  4/6/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Status: Enrolling
Updated: 4/6/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Statin Polyp Prevention Trial in Patients With Resected Colon Cancer
Status: Enrolling
Updated:  4/8/2016
Providence Cancer Center at Providence Hospital
mi
from
Mobile, AL
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Statin Polyp Prevention Trial in Patients With Resected Colon Cancer
Status: Enrolling
Updated: 4/8/2016
Providence Cancer Center at Providence Hospital
mi
from
Mobile, AL
Click here to add this to my saved trials
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Statin Polyp Prevention Trial in Patients With Resected Colon Cancer
Status: Enrolling
Updated:  4/8/2016
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Statin Polyp Prevention Trial in Patients With Resected Colon Cancer
Status: Enrolling
Updated: 4/8/2016
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Statin Polyp Prevention Trial in Patients With Resected Colon Cancer
Status: Enrolling
Updated:  4/8/2016
Kaiser Permanente - Deer Valley
mi
from
Antioch, CA
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Statin Polyp Prevention Trial in Patients With Resected Colon Cancer
Status: Enrolling
Updated: 4/8/2016
Kaiser Permanente - Deer Valley
mi
from
Antioch, CA
Click here to add this to my saved trials